Antimicrobial Resistance (AMR) is an increasingly wide-scale problem. Not contained by borders, and with the ability to turn minor infections into life threatening conditions, it is an issue that experts argue must be addressed in the present, not the future. &nbsp;Hear from Jennifer Schneider of Centauri Therapeutics, Franz-Werner Haas of LimmaTech Biologics and Neil Murray of ReNewVax on their unique approaches to tackling the threat of AMR, in the latest episode of the Optimum Perspectives Podcast.&nbsp;

Tackling the threat of AMR

Just in time for World ADC San Diego 2025 - a brand new episode of the Optimum Perspectives Podcast is live!&nbsp;Join Francois Bertelli of DISCO Pharmaceuticals, Stefano Gulla of Kling Biotherapeutics, and Michael Bauer of Novo Holdings, as they dive into the hot topic: ‘The ups and downs of ADCs – where to now?’&nbsp;Expect sharp insights and forward-looking perspectives on the evolving ADC landscape. Listen to the full episode here.

The ups and downs of ADCs – where to now?

The latest episode of Optimum Perspectives Podcast has just dropped, featuring LoQus23 Therapeutics’ Chief Scientific Officer and founder Caroline Benn! Listen as Caroline details the devastating effects of Huntington’s Disease on patients and families, her personal motivations for working in this therapeutic area, as well as LoQus23’s unique approach to battling the disease through their innovative small molecule approach.

Q&A with CSO Caroline Benn discussing LoQus23's unique approach to Huntington’s disease

On the latest episode of the Optimum Perspectives podcast, Optimum Strategic Communications’ Managing Director Eva Haas spoke with Curve Therapeutics CSO and Co-Founder Ali Tavassoli, who has today been awarded the Royal Society of Chemistry’s Interdisciplinary Prize.&nbsp;Listen below as Ali reflects on his scientific journey which has led him to this tremendous recognition, from what inspired his passion for science, to how he came to meet Curve CEO Simon Kerry,&nbsp;with whom he co-founded the Company. Curve’s is using its revolutionary gene-encoded Microcycle® platform to build a pipeline of innovative cyclic peptide and small molecule drugs addressing intracellular targets, with a focus on cancer, immunology and inflammation.

Q&A with Professor Ali Tavassoli of Curve Therapeutics: RSC Interdisciplinary Prize winner 2025

Listen to our Rare Disease Day Optimum Perspecitives podcast special featuring Tahira Mathur, Patient Advocate and Kate Adcock, Director of Research &amp; Innovation at Optimum's chosen charity Muscular Dystrophy UK, alongside Jasper Morrow, consultant neurologist at University College London Hospital.&nbsp;This emotional yet hopeful episode highlights the importance of raising awareness of rare conditions, while discussing patient care, diagnosis, and genetic testing for Muscular Dystrophy.&nbsp;If you would like to contribute to the life changing work of Muscular Dystrophy UK, or find out more about Tahira's story living with GNE myopathy, visit her page here: <a href="https://www.justgiving.com/campaign/tahira" rel="noopener noreferrer" target="_blank">Tahira's Team - JustGiving</a>

Stronger together: changing the future of muscle wasting condition

Want to know how bioengineered spider silk protein fibres can be applied within the textile, biomedical and automobile industries?&nbsp;In the latest episode of Optimum Perspectives, hear from Benoit Cugnet, Head of Fiber Business Unit at AMSilk, on how this German biotech is changing the face of advanced materials.

How bioengineered spider silk-based proteins are changing the world

Want to know how to prepare yourself for the perfect IPO on NASDAQ?&nbsp;Hear from Lynn Lewis, CEO of Gilmartin Group, Optimum’s US partner, on the considerations and milestones to reach before listing.&nbsp;

How to have a perfect IPO on NASDAQ

The latest epiosde of Optimum Perspectives Podcast features Germo Gericke, CMO of Ariceum Therapeutics. Listen as he discusses how the company aims to improve outcomes for patients with lung cancer with radioligand therapy this Lung Cancer Awareness Month.

Ariceum Therapeutics: Pioneering research into next-generation radiopharmaceutical therapy targeting hard-to-treat cancers

Great new insights in the Optimum Perspectives' latest podcast edition featuring Stefano Gullà, Chief Scientific Officer at Kling Biotherapeutics, about the growing role of B cell technology in cancer therapy.&nbsp;&nbsp;

Kling Biotherapeutics: Using  B cell tech to discover new targets and antibodies in cancer

Interviews with industry leaders of the healthcare sector.

<a href="https://www.optimumcomms.com/podcast/" rel="noopener noreferrer" target="_blank">Optimum Insights: Interviews with industry leaders of the healthcare sector in regular episodes highlighting the latest innovation and developments in life sciences.</a>Follow us on <a href="https://www.linkedin.com/company/optimum-strategic-communications/" rel="noopener noreferrer" target="_blank">Linkedin</a> and <a href="https://twitter.com/OptimumComms" rel="noopener noreferrer" target="_blank">Twitter</a> for news and highlights on the life sciences industry. Reach out via our contact page on our website: <a href="https://www.optimumcomms.com/" rel="noopener noreferrer" target="_blank">www.optimumcomms.com</a>

Optimum Perspectives

Social Media

Follow